1 |
Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. J Comput Assist Tomogr 2010;34:506-512
DOI
ScienceOn
|
2 |
Muhi A, Ichikawa T, Motosugi U, Sano K, Matsuda M, Kitamura T, et al. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma. J Magn Reson Imaging 2009;30:1005-1011
DOI
ScienceOn
|
3 |
Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N. Respiratory gated diffusionweighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008;18:486-492
DOI
ScienceOn
|
4 |
Heo SH, Jeong YY, Shin SS, Kim JW, Lim HS, Lee JH, et al. Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor. Korean J Radiol 2010;11:295-303
DOI
ScienceOn
|
5 |
Do RK, Chandarana H, Felker E, Hajdu CH, Babb JS, Kim D, et al. Diagnosis of liver fibrosis and cirrhosis with diffusionweighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol 2010;195:671-676
DOI
ScienceOn
|
6 |
Lewin M, Poujol-Robert A, Boelle PY, Wendum D, Lasnier E, Viallon M, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007;46:658-665
DOI
ScienceOn
|
7 |
Mwangi I, Hanna RF, Kased N, Malek P, Shiehmorteza M, Wolfson T, et al. Apparent diffusion coefficient of fibrosis and regenerative nodules in the cirrhotic liver at MRI. AJR Am J Roentgenol 2010;194:1515-1522
DOI
ScienceOn
|
8 |
Lee JM, Zech CJ, Bolondi L, Jonas E, Kim MJ, Matsui O, et al. Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging. Korean J Radiol 2011;12:403-415
DOI
ScienceOn
|
9 |
Tajima T, Honda H, Kuroiwa T, Yoshimitsu K, Irie H, Aibe H, et al. Radiologic features of intrahepatic bile duct adenoma: a look at the surface of the liver. J Comput Assist Tomogr 1999;23:690-695
DOI
ScienceOn
|
10 |
Kim YS, Rha SE, Oh SN, Jung SE, Shin YR, Choi BG, et al. Imaging findings of intrahepatic bile duct adenoma (peribiliary gland hamartoma): a case report and literature review. Korean J Radiol 2010;11:560-565
DOI
ScienceOn
|
11 |
Koga F, Tanaka H, Takamatsu S, Baba S, Takihara H, Hasegawa A, et al. A case of very large intrahepatic bile duct adenoma followed for 7 years. World J Clin Oncol 2012;3:63-66
DOI
ScienceOn
|
12 |
Maeda E, Uozumi K, Kato N, Akahane M, Inoh S, Inoue Y, et al. Magnetic resonance findings of bile duct adenoma with calcification. Radiat Med 2006;24:459-462
DOI
ScienceOn
|
13 |
Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008;47:97-104
|
14 |
Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254:47-66
DOI
ScienceOn
|
15 |
Feuerlein S, Pauls S, Juchems MS, Stuber T, Hoffmann MH, Brambs HJ, et al. Pitfalls in abdominal diffusion-weighted imaging: how predictive is restricted water diffusion for malignancy. AJR Am J Roentgenol 2009;193:1070-1076
DOI
ScienceOn
|
16 |
Goshima S, Kanematsu M, Kondo H, Yokoyama R, Kajita K, Tsuge Y, et al. Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 2008;28:691-697
DOI
ScienceOn
|
17 |
Lee MH, Kim SH, Park MJ, Park CK, Rhim H. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-bvalue diffusion-weighted imaging to distinguish welldifferentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol 2011;197:W868-W875
DOI
|
18 |
Craig JR, Peters RL, Edmondson HA. Tumors of the liver and intrahepatic bile ducts. In: Atlas of tumor pathology, 2nd series. fascicle 26. Washington DC: Armed Forces Institute of Pathology, 1990:56-62
|
19 |
Bhathal PS, Hughes NR, Goodman ZD. The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol 1996;20:858-864
DOI
ScienceOn
|
20 |
Edmondson HA. Tumors of the liver and intrahepatic bile ducts. In: Atlas of tumor pathology, fascicle 25. Washington DC: Armed Forces Institute of Pathology, 1958:19-29
|
21 |
Allaire GS, Rabin L, Ishak KG, Sesterhenn IA. Bile duct adenoma. A study of 152 cases. Am J Surg Pathol 1988;12:708-715
DOI
ScienceOn
|
22 |
Honda H, Onitsuka H, Yasumori K, Hayashi T, Ochiai K, Gibo M, et al. Intrahepatic peripheral cholangiocarcinoma: twophased dynamic incremental CT and pathologic correlation. J Comput Assist Tomogr 1993;17:397-402
DOI
ScienceOn
|
23 |
Hornick JL, Lauwers GY, Odze RD. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. Am J Surg Pathol 2005;29:381-389
DOI
ScienceOn
|